1. Home
  2. RMBS vs RDY Comparison

RMBS vs RDY Comparison

Compare RMBS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rambus Inc.

RMBS

Rambus Inc.

HOLD

Current Price

$146.35

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.62

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMBS
RDY
Founded
1990
1984
Country
United States
India
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
11.6B
IPO Year
1997
2001

Fundamental Metrics

Financial Performance
Metric
RMBS
RDY
Price
$146.35
$13.62
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$137.00
$16.90
AVG Volume (30 Days)
2.0M
2.5M
Earning Date
04-27-2026
05-12-2026
Dividend Yield
N/A
0.52%
EPS Growth
27.88
N/A
EPS
0.55
N/A
Revenue
$707,630,000.00
N/A
Revenue This Year
$16.01
$7.72
Revenue Next Year
$16.23
$3.50
P/E Ratio
$270.98
$18.67
Revenue Growth
27.13
N/A
52 Week Low
$53.11
$12.19
52 Week High
$161.80
$16.17

Technical Indicators

Market Signals
Indicator
RMBS
RDY
Relative Strength Index (RSI) 60.42 53.45
Support Level $90.31 $12.90
Resistance Level $161.80 $14.04
Average True Range (ATR) 9.32 0.24
MACD 1.36 0.03
Stochastic Oscillator 68.06 85.67

Price Performance

Historical Comparison
RMBS
RDY

About RMBS Rambus Inc.

Rambus Inc is a semiconductor company providing chips and silicon IP for data-intensive computing systems, focusing on data center and artificial intelligence (AI) infrastructure. The company is at the forefront of enabling the next era of AI-driven computing, addressing challenges of signal and power integrity at increasingly extreme data rates across the data center, edge, and client markets. It offers high-performance memory subsystems, with a balanced and diverse portfolio of products, IP, and patents that maximize performance and security in computationally intensive systems. The company operates in South Korea, Singapore, the United States, and other countries, with the majority of its revenue coming from South Korea.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: